Cerner Makes Personalized Medicine Push | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Cerner Makes Personalized Medicine Push

December 6, 2013
by Gabriel Perna
| Reprints

Cerner, the Kansas City-based electronic health record (EHR) vendor, is teaming with Cambridge, Mass.-based Claritas Genomics, a clinical genetic diagnostic testing company, to integrate personalized medicine technology into clinical practice.

Cerner and Claritas will advance personalized medicine by combining next generation sequence (NGS)-based diagnostic testing technology into practice. The two companies plan to develop a scalable laboratory for molecular diagnostics, tailored to NGS workflows. With Cerner, Claritas is getting existing, scalable computing infrastructure which can integrate the ordering of genomic sequencing tests, laboratory processing, results interpretation, return of results to the clinician and incorporation of the result in the patient's EHR.

Cerner’s subsidiary, Cerner Capital has invested in the company and become a minority shareholder.  Claritas formed as a spin out of Boston Children's Hospital. Early investors have also included Life Technologies and Cincinnati Children's Hospital.

"Cerner has long focused on the power of genomics and its impact to clinical processes, and this relationship will help advance the field and define a meaningful narrative in personalized medicine between the realms of research, diagnostics and clinical practice," Dick Flanigan, senior vice president with Cerner, said in a statement. “Claritas' focus on pediatrics is noteworthy, as that's when integrating genomics into clinical practice could be particularly impactful."

Other health IT vendors, such as IBM, as well as healthcare provider organizations such as MD Anderson have made similar pushes into linking clinical and genomic data.

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

$30M VC Fund Launched to Spur Innovation in Cardiovascular Care

The American Heart Association, together with Philips and UPMC, has announced the launch of Cardeation Capital, a $30 million collaborative venture capital fund designed to spur healthcare innovation in heart disease and stroke care.

Epic Wins Labor Dispute in Closely Divided Supreme Court Decision

Epic Systems Corporation won a major labor-law ruling in the Supreme Court on Monday, centering around the extent of corporations’ right to force employees to sign arbitration agreements, and with a 5-4 ruling in its favor

Survey: Two-Thirds of Physician Practices Seeking Out Value-Based Care Consulting Firms

Most physician organizations are not prepared for the move to value-based care, and 95 percent CIOs of group practices and large clinics state they do not have the information technology or staff in-house needed to transform value-based care end-to-end, according to a recent Black Book Market Research.

Cumberland Consulting Buys LinkEHR, Provider of Epic Help Desk Services

Cumberland Consulting Group, a healthcare consulting and services firm, has acquired LinkEHR, which provides remote application support, including Epic help desk services.

Population Health Tool that Provides City-Level Data Expands to 500 Cities

A data visualization tool that helps city officials understand the health status of their population, called the City Health Dashboard, has now expanded to 500 of the largest cities in the U.S., enabling local leaders to identify and take action around the most pressing health needs in their cities and communities.

Trump will Nominate Acting VA Secretary Wilkie for Permanent Position

Just a day after the Department of Veterans Affairs (VA) and Cerner inked their $10 billion EHR (electronic health record) deal, President Trump said he would be nominating Acting VA Secretary Robert Wilkie for the permanent position.